Search Results

There are 17103 results for: content related to: Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma

  1. Hepatitis C

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt033

  2. Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis

    Liver International

    Volume 31, Issue 3, March 2011, Pages: 401–411, Sanaa M. Kamal, Amany Ahmed, Sara Mahmoud, Leila Nabegh, Iman El Gohary, Isi Obadan, Tamer Hafez, Dahlia Ghoraba, Ahmed A. Aziz and Mona Metaoei

    Version of Record online : 11 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02435.x

    Corrected by:

    CORRIGENDA

    Vol. 31, Issue 4, 588, Version of Record online: 17 FEB 2011

  3. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus

    The Journal of Dermatology

    Volume 34, Issue 8, August 2007, Pages: 577–582, Yuki HASHIMOTO, Hiromi KANTO and Masatoshi ITOH

    Version of Record online : 3 AUG 2007, DOI: 10.1111/j.1346-8138.2007.00336.x

  4. Polyethylene glycol–interferon: Current status in hepatitis C virus therapy

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s3, December 2002, Pages: S344–S350, HEINER WEDEMEYER, JOHANNES WIEGAND, MARKUS CORNBERG and MICHAEL P MANNS

    Version of Record online : 23 SEP 2008, DOI: 10.1046/j.1440-1746.17.s3.26.x

  5. Pegylated interferon alpha-2b (Peg-IFN α-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN α-2b plus ribavirin

    Journal of Viral Hepatitis

    Volume 16, Issue 8, August 2009, Pages: 578–585, T. Oze, N. Hiramatsu, T. Yakushijin, M. Kurokawa, T. Igura, K. Mochizuki, K. Imanaka, A. Yamada, M. Oshita, H. Hagiwara, E. Mita, T. Ito, Y. Inui, T. Hijioka, S. Tamura, H. Yoshihara, E. Hayashi, A. Inoue, Y. Imai, M. Kato, Y. Yoshida, T. Tatsumi, K. Ohkawa, S. Kiso, T. Kanto, A. Kasahara, T. Takehara and N. Hayashi

    Version of Record online : 22 JUN 2009, DOI: 10.1111/j.1365-2893.2009.01116.x

  6. Characterization of elevated alanine aminotransferase levels during pegylated-interferon α-2b plus ribavirin treatment for chronic hepatitis C

    Hepatology Research

    Volume 41, Issue 2, February 2011, Pages: 118–125, Yo-hei Aoki, Shogo Ohkoshi, Satoshi Yamagiwa, Masahiko Yano, Hiromichi Takahashi, Nobuo Waguri, Kentaro Igarashi, Soh-ichi Sugitani, Toru Takahashi, Toru Ishikawa, Tomoteru Kamimura, Hiroto Wakabayashi, Toshiaki Watanabe, Yasunobu Matsuda, Minoru Nomoto and Yutaka Aoyagi

    Version of Record online : 26 JAN 2011, DOI: 10.1111/j.1872-034X.2010.00749.x

  7. Pegylated versus standard interferon plus ribavirin in chronic hepatitis C genotype 4: A systematic review and meta-analysis

    Hepatology Research

    Volume 43, Issue 12, December 2013, Pages: 1255–1263, Abdulrahman A. Aljumah and Mohammad Hassan Murad

    Version of Record online : 4 MAR 2013, DOI: 10.1111/hepr.12084

  8. Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

    Hepatology Research

    Volume 40, Issue 4, April 2010, Pages: 347–368, Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshihito Itoh, Yusuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi and Masatoshi Kudo

    Version of Record online : 29 MAR 2010, DOI: 10.1111/j.1872-034X.2010.00642.x

  9. Pegylated interferon α-2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase

    Hepatology Research

    Volume 42, Issue 1, January 2012, Pages: 33–41, Mosaburo Kainuma, Norihiro Furusyo, Koichi Azuma, Eiji Kajiwara, Kazuhiro Takahashi, Hideyuki Nomura, Yuichi Tanabe, Takeaki Satoh, Toshihiro Maruyama, Makoto Nakamuta, Kazuhiro Kotoh, Shinji Shimoda, Jun Hayashi and the Kyushu University Liver Disease Study (KULDS) Group

    Version of Record online : 22 NOV 2011, DOI: 10.1111/j.1872-034X.2011.00907.x

  10. You have free access to this content
    Guidelines for the Management of Hepatitis C Virus Infection

    Hepatology Research

    Volume 43, Issue 1, January 2013, Pages: 1–34, Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of Hepatology

    Version of Record online : 18 JAN 2013, DOI: 10.1111/hepr.12020

  11. You have free access to this content
    Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: A randomized controlled trial

    Hepatology

    Volume 50, Issue 4, October 2009, Pages: 1045–1055, Stuart K. Roberts, Martin D. Weltman, Darrell H. G. Crawford, Geoffrey W. McCaughan, William Sievert, Wendy S. Cheng, William Rawlinson, Paul V. Desmond, Phillipa S. Marks, Motoko Yoshihara, Bishoy Rizkalla, Jean K. DePamphilis, Gregory J. Dore and Chariot Study Group

    Version of Record online : 15 JUN 2009, DOI: 10.1002/hep.23130

  12. Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 7, July 2012, Pages: 1233–1240, Eiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, Kazuhiro Takahashi, Hideyuki Nomura, Yuichi Tanabe, Takeaki Satoh, Toshihiro Maruyama, Makoto Nakamuta, Kazuhiro Kotoh, Koichi Azuma, Kazufumi Dohmen, Shinji Shimoda, Jun Hayashi and The Kyushu University Liver Disease Study [KULDS] Group

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1440-1746.2011.06965.x

  13. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  14. Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine

    Hepatology Research

    Volume 37, Issue s1, July 2007, Pages: S55–S61, Patrick Marcellin, Olivier Lada and Tarik Asselah

    Version of Record online : 9 JUL 2007, DOI: 10.1111/j.1872-034X.2007.00106.x

  15. Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 3, March 2014, Pages: 251–258, Tomoyuki Tsunoda, Ayano Inui, Manari Kawamoto, Tsuyoshi Sogo, Haruki Komatsu and Tomoo Fujisawa

    Version of Record online : 24 APR 2013, DOI: 10.1111/hepr.12118

  16. You have free access to this content
    Pharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG-IFN α-2a (40KD) (PEGASYS®)

    British Journal of Clinical Pharmacology

    Volume 67, Issue 3, March 2009, Pages: 280–287, Brian Bressler, Ka Wang, Joseph F. Grippo and E. Jenny Heathcote

    Version of Record online : 20 MAR 2009, DOI: 10.1111/j.1365-2125.2008.03349.x

  17. Anti-hepatitis C virus activity of albinterferon alfa-2b in cell culture

    Hepatology Research

    Volume 37, Issue 11, November 2007, Pages: 941–947, Chen Liu, Haizhen Zhu, G. Mani Subramanian, Paul A. Moore, Yiling Xu and David R. Nelson

    Version of Record online : 15 JUN 2007, DOI: 10.1111/j.1872-034X.2007.00142.x

  18. Appropriate use of interferon for treatment of chronic hepatitis B

    Hepatology Research

    Volume 37, Issue s1, July 2007, Pages: S47–S54, Jia-Horng Kao

    Version of Record online : 9 JUL 2007, DOI: 10.1111/j.1872-034X.2007.00105.x

  19. Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin

    Journal of Viral Hepatitis

    Volume 16, Issue 8, August 2009, Pages: 586–594, N. Hiramatsu, T. Oze, T. Yakushijin, Y. Inoue, T. Igura, K. Mochizuki, K. Imanaka, A. Kaneko, M. Oshita, H. Hagiwara, E. Mita, T. Nagase, T. Ito, Y. Inui, T. Hijioka, K. Katayama, S. Tamura, H. Yoshihara, Y. Imai, M. Kato, Y. Yoshida, T. Tatsumi, K. Ohkawa, S. Kiso, T. Kanto, A. Kasahara, T. Takehara and N. Hayashi

    Version of Record online : 22 JUN 2009, DOI: 10.1111/j.1365-2893.2009.01106.x

  20. You have free access to this content
    Review article: novel therapeutic options for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 10, May 2008, Pages: 866–884, E. CHOLONGITAS and G. V. PAPATHEODORIDIS

    Version of Record online : 12 FEB 2008, DOI: 10.1111/j.1365-2036.2008.03644.x